Interleukin 18 and transforming growth factor β1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids
Authors:
- Janusz MyśliwiecJMJanusz Myśliwiec
- Adam KrętowskiAKAdam Krętowski
- Agnieszka StępieńASAgnieszka Stępień
- Katarzyna MirończukKMKatarzyna Mirończuk
- Ida KinalskaIKIda Kinalska
- 1 April 2003
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 3 (4) , 549-552
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Elevated Levels of Circulating Interleukin-18 in Human Immunodeficiency Virus-Infected Individuals: Role of Peripheral Blood Mononuclear Cells and Implications for AIDS PathogenesisJournal of Virology, 2002
- Serum Th1 and Th2 Profile Cytokine Level Changes in Patients with Graves' Ophthalmopathy Treated with CorticosteroidsHormone and Metabolic Research, 2001
- Interleukin-18: A novel cytokine in inflammatory rheumatic diseaseArthritis & Rheumatism, 2001
- A novel role for interleukin-18 in human natural killer cell death: High serum levels and low natural killer cell numbers in patients with systemic autoimmune diseasesArthritis & Rheumatism, 2001
- Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18The Journal of Immunology, 2001
- Increased Levels of Serum lnterleukin-18 in Graves' DiseaseThyroid®, 2000
- Interleukin 18: a pleiotropic participant in chronic inflammationImmunology Today, 2000
- The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune DiseasesJournal of Autoimmunity, 2000
- Cytokines in the Evolution of Graves' OphthalmopathyAutoimmunity, 1997
- Detection and localization of cytokine immunoreactivity in retro‐ocular connective tissue in Graves' opthalmopathyEuropean Journal of Clinical Investigation, 1993